TATT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. Despite strong fundamentals and consistently bullish Wall Street ratings, the near-term technical setup is weakening (negative/expanding MACD histogram, RSI 40) and the pattern-based forward probabilities tilt slightly negative over the next week/month. If you already own it, holding makes sense into the next catalyst (earnings on 2026-02-11). If you are looking to initiate immediately, the current price near the pivot (52) is not an attractive risk/reward entry versus nearby support around ~49.9.
Trend/Structure: Moving averages are still constructive (SMA_5 > SMA_20 > SMA_200), indicating the broader trend remains bullish. Momentum: MACD histogram is -0.527 and negatively expanding, which is a bearish momentum signal suggesting downside pressure is building. RSI_6 is ~39.9 (neutral-to-soft), not yet oversold but weak. Levels: Pivot ~52.04 is essentially where the stock is trading post-market (51.89). Immediate resistance is ~54.22 then ~55.56; key support is ~49.86 then ~48.52. Near-term bias: The candlestick-pattern analogs suggest modest downside risk (next day -0.16%, next week -2.25%, next month -2.34%), aligning with the weakening MACD.
Intellectia Proprietary Trading Signals
Analyst sentiment remains strongly positive: multiple Buys/initiations and recent price target increases (e.g., Truist raised to $61 on 2026-01-09; Lake Street/Benchmark at $53).
Operational/industry tailwinds cited by analysts: rising aircraft production, sustained aftermarket demand, and TAT’s growing backlog/pipeline.
Strategic relationship with Honeywell viewed as a meaningful long-run growth lever.
Upcoming event: QDEC 2025 earnings on 2026-02-11 (After Hours) could act as a catalyst if results/guide beat expectations.
Positioning/flows: Hedge fund and insider activity described as neutral (no notable selling pressure flagged).
Technical momentum is deteriorating (MACD negative and worsening), increasing the risk of a pullback despite bullish moving averages.
Short-term statistical outlook (pattern-based) points to mild downside over the next week/month.
Earnings risk: with earnings coming soon (2026-02-11), any miss or cautious outlook can pressure the stock.
No supportive news flow in the past week to counteract the current momentum fade.
Congress/political activity: No recent congress trading data available (no visible ‘follow-the-money’ catalyst).
Latest reported quarter: 2025/Q3. Growth was strong and improving: Revenue $46.235M (+14.28% YoY), Net Income $4.841M (+68.97% YoY), EPS $0.37 (+42.31% YoY). Profitability trended up: Gross margin 25.09% (up +19.70% YoY), consistent with the ‘clean operating quarter’ narrative from analysts. Overall, fundamentals support the longer-term bull case, but they don’t override the current weaker near-term entry setup.
Recent trend: Analyst coverage is uniformly bullish with multiple Buy ratings, and price targets have generally moved higher over the last few months (Lake Street initiated Buy PT $53; Benchmark initiated Buy PT $53; Stifel raised PT to $47; Truist most recently raised PT to $61 after previously trimming to $52 post-Q3). Wall Street pros: sustained aftermarket demand, backlog/pipeline strength, margin expansion/operational efficiencies, and Honeywell relationship expanding addressable market. Wall Street cons: elevated sector valuations and some conservatism around the timing/scale of specific opportunities (e.g., Truist moderated 2026 revenue estimates around the 131 APU opportunity).
